Clinical Trial 23763

• Overview

  Study Title:

  Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring

• Treatments

  Therapies:

  BRAF/MEK-inhibitor therapy; Immunotherapy; Surgery

  Medications:

  BMS-936558 (Nivolumab); GSK1120212 (Trametinib); GSK2118436 (dabrafenib); Ipilimumab (); Nivolumab (Opdivo); Trametinib (); Yervoy (Ipilimumab); dabrafenib ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.